InvestorsHub Logo
Followers 33
Posts 2042
Boards Moderated 0
Alias Born 11/06/2011

Re: None

Thursday, 07/12/2018 1:48:09 PM

Thursday, July 12, 2018 1:48:09 PM

Post# of 34576
I just received a response regarding an inquiry for information on any Marker trials currently ongoing. Below is a list of all trials that $TPIV will have rights to at the close of the merger:


ADSPAM: NCT02494167

TACTAL: NCT01333046

TACTAM: NCT02291848

TACTIC: NCT03093350

TACTOPS: NCT03192462

STELLA: NCT02475707

Combine that with the trials that we already have and we look to be in pretty good shape to have a steady stream of data over the next few years. I am still waiting for a response from the Mayo Clinic in regard to the 280 patient DoD funded trial they are running and will report back if I get any info from them.


Friends don't let friends place market orders

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News